• HORIZON-HLTH-2024-DISEASE-09-01: European Partnership: One Health AntiMicrobial Resistance

• HORIZON-HLTH-2024-IND-06-08: Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)
• HORIZON-HLTH-2024-IND-06-09: Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators

• HORIZON-HLTH-2024-TOOL-11-02: Bio-printing of living cells for regenerative medicine

• HORIZON-HLTH-2024-DISEASE-08-12: Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness
• HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Hostpathogen interactions of infectious diseases with epidemic potential

Pre-proposal

• HORIZON-HLTH-2024-DISEASE-03-08-two-stage: Comparative effectiveness research for healthcare interventions in areas of high public health need
• HORIZON-HLTH-2024-DISEASE-03-11-two-stage: Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness
• HORIZON-HLTH-2024-DISEASE-03-13-two-stage: Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders
• HORIZON-HLTH-2024-DISEASE-03-14-two-stage: Tackling high-burden for patients, under-researched medical conditions

Pre-proposal

• HORIZON-HLTH-2024-CARE-04-04-two-stage: Access to health and care services for people in vulnerable situations

COFUND

• HORIZON-HLTH-2023-DISEASE-07-01: European Partnership on Rare Diseases

Pre-proposal

• HORIZON-HLTH-2024-ENVHLTH-02-06-two-stage: The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution

Pre-proposal

• HORIZON-HLTH-2024-TOOL-05-06-two-stage: Innovative non-animal human-based tools and strategies for biomedical research

Pre-proposal

• HORIZON-HLTH-2024-STAYHLTH-01-02-two-stage: Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society
• HORIZON-HLTH-2024-STAYHLTH-01-05-two-stage: Personalised prevention of noncommunicable diseases - addressing areas of unmet needs using multiple data sources

Cut-off date

First EIT Health flagship call. This is an open call for cross-pillar activities for three of the four flagships:

• New models to deliver healthcare
• Facilitating the uptake of digital medical devices in Europe
• Harnessing the full potential of health data for innovation

Are you part of an early-stage medtech or digital health start-up? Get a clear and valid proof of concept, so you can launch your business into a European market.
In this six-week, online programme, experts and mentors will help you understand and refine your project, business and financial plan.

Deadline for obligatory "Intent to apply": 23.05.2023
Deadline for proposals: 13.06.2023

The objective of this call is to encourage the optimization of patient care pathways and contribute to the transition towards more sustainable, efficient, resilient, ethical, high-quality, and accessible person-centered healthcare systems.

Call for Proposals for ‘Multinational Research Projects on Ethical, Legal, and Social Aspects (ELSA) of Neuroscience’.

The User Validation Labs (ULabs) programme connects you with EIT Health partners in Europe that can help you organise and execute a validation study for your start-up’s innovation.

EIT Health’s Bridgehead programme brings together health entrepreneurs who want to grow their business in the European market with incubators and accelerators who have the expertise and resources to make it happen.

The programme pairs early-stage start-ups with the resources they need to validate their problem-solution, achieve product-market fit, and secure investment opportunities.

Training programme that showcases life sciences and health tech start-ups to leading experts and investors across Europe. The programme awards the best business concepts, fast-tracking start-ups to become part of the EIT Health Community.

The aim of this call is to build knowledge to prepare for and succeed with a dietary shift towards a healthier and more sustainable diet. This demands a system approach. Improved use of resources and designing new foods will be a driving force.

• HORIZON-HLTH-2023-DISEASE-03-01: Novel approaches for palliative and end-of-life care for non-cancer patients
• HORIZON-HLTH-2023-DISEASE-03-03: Interventions in city environments to reduce risk of non-communicable disease (Global Alliance for Chronic Diseases - GACD)
• HORIZON-HLTH-2023-DISEASE-03-04: Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential
• HORIZON-HLTH-2023-DISEASE-03-05: Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks
• HORIZON-HLTH-2023-DISEASE-03-06: Towards structuring brain health research in Europe
• HORIZON-HLTH-2023-DISEASE-03-07: Relationship between infections and noncommunicable diseases
• HORIZON-HLTH-2023-DISEASE-03-17: Pandemic preparedness and response: Understanding vaccine induced-immunity
• HORIZON-HLTH-2023-DISEASE-03-18: Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential

• HORIZON-HLTH-2023-CARE-04-01: Maintaining access to regular health and care services in case of cross-border emergencies
• HORIZON-HLTH-2023-CARE-04-02: Resilience and mental wellbeing of the health and care workforce
• HORIZON-HLTH-2023-CARE-04-03: Environmentally sustainable and climate neutral health and care systems 

• HORIZON-HLTH-2023-ENVHLTH-02-01: Planetary health: understanding the links between environmental degradation and health impacts
• HORIZON-HLTH-2023-ENVHLTH-02-02: Evidence-based interventions for promotion of mental and physical health in changing working environments (post-pandemic workplaces)
• HORIZON-HLTH-2023-ENVHLTH-02-03: Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties
• HORIZON-HLTH-2023-ENVHLTH-02-04: Global coordination of exposome research

• HORIZON-HLTH-2023-TOOL-05-01: Clinical trials of combined Advanced Therapy Medicinal Products (ATMPs)
• HORIZON-HLTH-2023-TOOL-05-03: Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management
• HORIZON-HLTH-2023-TOOL-05-04: Better integration and use of health-related realworld and research data, including genomics, for improved clinical outcomes
• HORIZON-HLTH-2023-TOOL-05-05: Harnessing the potential of real-time data analysis and secure Point-of-Care computing for the benefit of person-centred health and care delivery
• HORIZON-HLTH-2023-TOOL-05-08: Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats
• HORIZON-HLTH-2023-TOOL-05-09: Developing a Data Quality and Utility Label for the European Health Data Space

• HORIZON-HLTH-2023-STAYHLTH-01-01: The Silver Deal - Person-centred health and care in European regions

COFUND

• HORIZON-HLTH-2023-CARE-08-01: European Partnership on Personalised Medicine

• HORIZON-HLTH-2023-IND-06-01: Supporting the uptake of innovative Health Technology Assessment (HTA) methodology and advancing HTA expertise across EU
• HORIZON-HLTH-2023-IND-06-02: Expanding the European Electronic Health Record exchange Format to improve interoperability within the European Health Data Space
• HORIZON-HLTH-2023-IND-06-04: Modelling and simulation to address regulatory needs in the development of orphan and paediatric medicines
• HORIZON-HLTH-2023-IND-06-05: Mapping the hurdles for the clinical applications of Advanced Therapy Medicinal Products (ATMPs)
• HORIZON-HLTH-2023-IND-06-07: Development and harmonisation of methodologies for assessing digital health technologies in Europe

• HORIZON-MISS-2023-CANCER-01-01: Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients
• HORIZON-MISS-2023-CANCER-01-02: Enhance primary cancer prevention through sustainable behavioural change
• HORIZON-MISS-2023-CANCER-01-03: Pragmatic clinical trials on minimally invasive diagnostics
• HORIZON-MISS-2023-CANCER-01-04: Establish best practices and tools to improve the quality of life for childhood cancer patients, survivors and their families in European regions

• Topic 1: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
• Topic 2: Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
• Topic 3: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency
• Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases
• Topic 5: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences

The aim of this call is to develop novel strategies and targeted approaches to identify, understand, and modify determinants and mechanisms of diet-related behaviour and physical activity as well as sedentary behaviour, which have the potential to break through the cycles maintaining unhealthy behaviours and lifestyles and to reduce health inequalities.

Pre-proposal

To take action against the growing global threat of increasing resistance in pathogenic organisms, and the spread of antimicrobial resistance (AMR), this call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance.

Call for Proposals for Transnational Research Projects on Mechanisms of Resilience and Vulnerability to Environmental Challenges in Mental Health.

The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative launched a transnational call for large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases for ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that seek to improve the understanding of the complex and multifactorial pathogenesis of neurodegenerative diseases.

Pre-proposal

The objective of this call is to conduct efficient, innovative and high-quality natural history studies which will facilitate understanding of the disease’s or group of disorders’ progression throughout the lifespan of a patient. The goal of these studies is to collect and analyze comprehensive patient data to define targets for future therapies, taking into consideration innovation, safety, and efficacy.

Pre-proposal

Proposals must present research that addresses one or both of the following topics:

1. Repair and/or regeneration of the heart and/or the blood vessels
2. Chronic heart failure and atrial fibrillation

The Networking Support Scheme (NSS) of the European Joint Programme on Rare Diseases is funding quarterly networking initiatives in the field of rare diseases and rare cancers, bringing together health care professionals, researchers, patient advocacy groups, Early Career Scientists and other relevant stakeholders.

For the translation and implementation of future research outcomes into clinical practice, as well as for shaping future research priorities, it is essential to form synergies in the research community, to overcome gaps and hurdles, to build overarching networks, and to generate harmonizing concepts and ideas.